Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze LIFE.U.TO stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate LIFE.U.TO investment potential.

What is LIFE.U.TO stock price today?

Get real-time LIFE.U.TO stock price, historical data, and price charts on Financhill. Track LIFE.U.TO performance with our advanced analysis tools.

Is LIFE.U.TO a good investment?

Evaluate LIFE.U.TO investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy LIFE.U.TO stock?

To buy LIFE.U.TO stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of LIFE.U.TO?

View detailed market capitalization data and company valuation metrics for LIFE.U.TO on our comprehensive analysis page.

What is the P/E ratio of LIFE.U.TO?

Use our fundamental analysis tools to view LIFE.U.TO P/E ratio and compare valuation metrics with industry peers.

What are LIFE.U.TO earnings?

View LIFE.U.TO earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Evolve Global Healthcare Enhanced Yield ETF Un USD Stock Predictions

Most Pre-IPO Big Tech Shifts Look Like This at the Start

*DISCLOSURE: This is a paid advertisement for Immersed Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks immersed.com

Buy

LIFE.U.TO
Evolve Global Healthcare Enhanced Yield ETF Un USD

Last Price:

$19.86

Seasonality Move:

-2.21%

7 Day Trial

ALL ACCESS PASS

$ 7

When an AI Platform Gets Pulled by Too Much Demand

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

Evolve Global Healthcare Enhanced Yield ETF Un USD Stock Forecast

Over the next 52 weeks, Evolve Global Healthcare Enhanced Yield ETF Un USD has on average historically fallen by 1.7% based on the past 5 years of stock performance.
Evolve Global Healthcare Enhanced Yield ETF Un USD has fallen lower in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
Is Evolve Global Healthcare Enhanced Yield ETF Un USD Stock Undervalued?

The current Evolve Global Healthcare Enhanced Yield ETF Un USD [LIFE.U.TO] share price is $20.05. The Score for LIFE.U.TO is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
LIFE.U.TO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Evolve Global Healthcare Enhanced Yield ETF Un USD Stock Go Up Next Year?

Over the next 52 weeks, Evolve Global Healthcare Enhanced Yield ETF Un USD has on average historically fallen by 1.7% based on the past 5 years of stock performance.

Evolve Global Healthcare Enhanced Yield ETF Un USD Stock Rating

Buy

Evolve Global Healthcare Enhanced Yield ETF Un USD (LIFE.U.TO) is a Buy

Is Evolve Global Healthcare Enhanced Yield ETF Un USD overpriced?

Evolve Global Healthcare Enhanced Yield ETF Un USD has fallen lower in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%

Evolve Global Healthcare Enhanced Yield ETF Un USD Stock Price History

Is LIFE.U.TO stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LIFE.U.TO is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:

TSX

Country:

Industry:

Sector:

Type:

etf

Website:

52-Week Data

52-Week High:

20.94

52-Week Low:

17.29

Prediction Charts

Market Cap:

Price in USD:

20.05

Volume:

Beta:

0.76

Technical Analysis

SMA50:

20.04

SMA100:

19.59

SMA200:

19.15

52-Wk Change:

-0.4%

Stock Predictions

Is Evolve Global Healthcare Enhanced Yield ETF Un USD stock public?

Yes, Evolve Global Healthcare Enhanced Yield ETF Un USD is a publicly traded company.
What is the Evolve Global Healthcare Enhanced Yield ETF Un USD stock quote today?

The Evolve Global Healthcare Enhanced Yield ETF Un USD stock price is 20.05 USD today.
How to buy Evolve Global Healthcare Enhanced Yield ETF Un USD stock online?

You can buy Evolve Global Healthcare Enhanced Yield ETF Un USD shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Jan-20	20.02	20.02	20.02	20.02
Jan-21	20.02	20.27	20.02	20.02
Jan-22	20.02	20.24	20.02	20.02
Jan-23	20.19	20.23	20.20	20.19
Jan-26	20.20	20.35	20.20	20.20
Jan-27	20.20	20.43	20.20	20.20
Jan-28	20.20	20.10	20.20	20.20
Jan-29	20.08	20.11	20.11	20.08
Jan-30	20.00	20.05	20.02	20.00
Feb-2	20.02	20.13	20.02	20.02
Feb-3	20.02	19.83	20.02	20.02
Feb-4	20.01	19.90	20.01	20.01
Feb-5	19.86	19.76	19.86	19.86
Feb-6	19.86	20.05	19.86	19.86

Evolve Global Healthcare Enhanced Yield ETF Un USD Earnings

Data Unavailable

Evolve Global Healthcare Enhanced Yield ETF Un USD Forecast Revenue Growth